在预防心力衰竭猝死方面，神经激素拮抗剂优于植入式心脏复律除颤器。 - Suppr

Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.

作者信息

Packer Milton

机构信息

Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas; Imperial College, London, United Kingdom.

出版信息

JACC Heart Fail. 2019 Oct;7(10):902-906. doi: 10.1016/j.jchf.2019.05.013. Epub 2019 Sep 11.

DOI:10.1016/j.jchf.2019.05.013

PMID:31521684

Abstract

摘要

相似文献

Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.在预防心力衰竭猝死方面，神经激素拮抗剂优于植入式心脏复律除颤器。

JACC Heart Fail. 2019 Oct;7(10):902-906. doi: 10.1016/j.jchf.2019.05.013. Epub 2019 Sep 11.

ICDs Are Still an Effective Therapy to Prevent Sudden Cardiac Death in Heart Failure.植入式心脏除颤器仍是预防心力衰竭患者心源性猝死的有效疗法。

JACC Heart Fail. 2019 Oct;7(10):907-910. doi: 10.1016/j.jchf.2019.08.001. Epub 2019 Sep 11.

Waiting Period Before Implantable Cardioverter-Defibrillator Implantation in Newly Diagnosed Heart Failure With Reduced Ejection Fraction: A Window of Opportunity.射血分数降低的新诊断心力衰竭患者植入植入式心脏复律除颤器前的等待期：一个机会之窗。

Circ Heart Fail. 2017 Nov;10(11). doi: 10.1161/CIRCHEARTFAILURE.117.004478.

Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?心力衰竭伴射血分数降低患者的猝死预防：我们是否仍需要植入式心脏复律除颤器进行一级预防？

Eur J Heart Fail. 2022 Sep;24(9):1460-1466. doi: 10.1002/ejhf.2594. Epub 2022 Jul 16.

Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.心力衰竭和射血分数降低患者的药物和心脏植入电子设备治疗效果：系统评价和网络荟萃分析。

Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e006951. doi: 10.1161/CIRCEP.118.006951. Epub 2019 Jun 4.

Compelling First-Line Drug and Device Therapies for the Prevention of Sudden Death in Patients With Chronic Heart Failure and a Reduced Ejection Fraction Who Are Candidates for an Implantable Cardioverter-Defibrillator.用于预防慢性心力衰竭且射血分数降低、适合植入式心脏复律除颤器治疗的患者猝死的一线药物和器械疗法。

Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e007430. doi: 10.1161/CIRCEP.119.007430. Epub 2019 Jun 4.

[Cardioverter-defibrillator (ICD) and resynchronization in every patient with cardiac failure].[心力衰竭患者均应使用心脏复律除颤器（ICD）及心脏再同步化治疗]

Dtsch Med Wochenschr. 2006 Oct 13;131(41):2297-8; author reply 2298. doi: 10.1055/s-2006-954815.

[Heart failure].[心力衰竭]

Nihon Rinsho. 2002 Jul;60(7):1422-6.

[Congestive heart failure and arrhythmia].[充血性心力衰竭与心律失常]

Nihon Rinsho. 1993 May;51(5):1354-61.

Use of implantable cardioverter-defibrillators.植入式心脏复律除颤器的使用。

Future Cardiol. 2010 Nov;6(6):859-70. doi: 10.2217/fca.10.99.

引用本文的文献

Cardiovascular magnetic resonance left ventricular 4D-flow: differences in flow components and kinetic energy across heart failure spectrum.心血管磁共振左心室四维血流：心力衰竭谱中血流成分和动能的差异。

Eur Heart J Imaging Methods Pract. 2025 May 14;3(1):qyaf059. doi: 10.1093/ehjimp/qyaf059. eCollection 2025 Jan.

Heart Rate and Prognosis of Heart Failure with Reduced Ejection Fraction in Women and Men in Sinus Rhythm.窦性心律的女性和男性射血分数降低的心力衰竭患者的心率与预后

J Clin Med. 2025 Mar 15;14(6):1995. doi: 10.3390/jcm14061995.

The Impact of Angiotensin Receptor-Neprilysin Inhibitors on Arrhythmias in Patients with Heart Failure: A Systematic Review and Meta-analysis.血管紧张素受体脑啡肽酶抑制剂对心力衰竭患者心律失常的影响：一项系统评价和荟萃分析。

J Innov Card Rhythm Manag. 2022 Sep 15;13(9):5164-5175. doi: 10.19102/icrm.2022.130905. eCollection 2022 Sep.

Efficacy and safety profile of angiotensin receptor neprilysin inhibitors in the management of heart failure: a systematic review and meta-analysis of randomized controlled trials.血管紧张素受体脑啡肽酶抑制剂在心力衰竭管理中的疗效和安全性：系统评价和随机对照试验的荟萃分析。

Heart Fail Rev. 2023 Jul;28(4):905-923. doi: 10.1007/s10741-022-10273-3. Epub 2022 Oct 3.

Potassium binders for patients with heart failure? The real enlightenment of the DIAMOND trial.心力衰竭患者的钾结合剂？DIAMOND试验的真正启示。

Eur Heart J. 2022 Nov 1;43(41):4374-4377. doi: 10.1093/eurheartj/ehac399.

Sacubitril/valsartan versus angiotensin inhibitors and arrhythmia endpoints in heart failure with reduced ejection fraction.沙库巴曲缬沙坦与血管紧张素抑制剂及射血分数降低的心力衰竭患者心律失常终点事件的关系

Heart Rhythm O2. 2021 Dec 17;2(6Part B):724-732. doi: 10.1016/j.hroo.2021.09.009. eCollection 2021 Dec.

Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction.基于证据的心力衰竭和射血分数降低型基础药物快速排序。

Eur J Heart Fail. 2021 Jun;23(6):882-894. doi: 10.1002/ejhf.2149. Epub 2021 May 7.

Guideline-directed medical therapy for heart failure does not exist: a non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fraction.指南导向的心力衰竭治疗并不存在：一种非评判性的框架，用于描述对射血分数降低的心力衰竭患者进行基于证据的药物治疗的依从程度。

Eur J Heart Fail. 2020 Oct;22(10):1759-1767. doi: 10.1002/ejhf.1857. Epub 2020 May 20.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neurohormonal Antagonists Are Preferred to an Implantable Cardioverter-Defibrillator in Preventing Sudden Death in Heart Failure.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献